EDITORIAL

1. New markers of fibrosis in hepatitis C: A step towards the Holy Grail?
2. Can rifaximin for hepatic encephalopathy be discontinued during broad-spectrum antibiotic treatment?
3. Insights into skullcap herb-induced liver injury
4. Non-invasive assessment of esophageal varices: Status of today
5. Contemporary concepts of prevention and management of gastroesophageal variceal bleeding in liver cirrhosis patients
6. Advancements in autoimmune hepatitis management: Perspectives for future guidelines
7. Interleukins in liver disease treatment
8. Changes in the etiology of liver cirrhosis and the corresponding management strategies

REVIEW

1. Metabolic-associated fatty liver disease and sarcopenia: A double whammy
2. Precision targeting in hepatocellular carcinoma: Exploring ligandreceptor mediated nanotherapy

MINIREVIEWS

1. Dynamic changes and clinical value of lipocalin 2 in liver diseases caused by microbial infections
2. Recent advances in the diagnosis of drug-induced liver injury

ORIGINAL ARTICLE

1. Predicting major adverse cardiovascular events after orthotopic liver transplantation using a supervised machine learning model: A cohort study
2. Effects of SARS-CoV-2 infection on incidence and treatment strategies of hepatocellular carcinoma in people with chronic liver disease
3. Epidemiological survey of cystic echinococcosis in southwest China: From the Qinghai-Tibet plateau to the area of Yunnan
4. Predictors of portal vein thrombosis after splenectomy in patients with cirrhosis
5. Evaluation of G3BP1 in the prognosis of acute and acute-on-chronic liver failure after the treatment of artificial liver support system
6. Yinhuang granule alleviates carbon tetrachloride-induced liver fibrosis in mice and its mechanism

CASE REPORT

1. Coinfection with hepatic cystic and alveolar echinococcosis with abdominal wall abscess and sinus tract formation: A case report
2. Autoimmune hepatitis and primary sclerosing cholangitis after direct-acting antiviral treatment for hepatitis C virus: A case report

LETTER TO THE EDITOR

1. Anti-oxidative stress treatment and current clinical trials